Research - Bellevue, Washington, United States
Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next generation gene editing therapy utilizing regulation of epigenetic genome for a variety of diseases. Founded in 2021 by leading scientists who focus on making novel treatment for serious prevalent and rare diseases. We now have multiple product candidates in the pipeline, including treatment for ocular, neurodegeneration, metabolic, and rare diseases.